Medicare HMO Penetration and Mortality Outcomes of Ischemic Stroke
Who Will Be Denied Medicare Prescription Drug Subsidies Because of the Asset Test?
Medicare and Medicaid Managed Care: A Tale of Two Trajectories
Do Drug Formulary Policies Reflect Evidence of Value?
Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy
Value-based Insurance Design: A "Clinically Sensitive" Approach to Preserve Quality of Care and Contain Costs
